• Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
  
• Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
  

PubMed=11261825; DOI=10.1023/A:1006461422273
Santner S.J., Dawson P.J., Tait L., Soule H.D., Eliason J.F., Mohamed A.N., Wolman S.R., Heppner G.H., Miller F.R.
Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.
Breast Cancer Res. Treat. 65:101-110(2001)

PubMed=14523048; DOI=10.1172/JCI18899; PMCID=PMC198530
Tang B.-W., Vu M., Booker T., Santner S.J., Miller F.R., Anver M.R., Wakefield L.M.
TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.
J. Clin. Invest. 112:1116-1124(2003)

PubMed=20169162; DOI=10.1371/journal.pone.0009201; PMCID=PMC2821407
Kadota M., Yang H.H., Gomez B.P., Sato M., Clifford R.J., Meerzaman D., Dunn B.K., Wakefield L.M., Lee M.P.
Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.
PLoS ONE 5:E9201-E9201(2010)

PubMed=20543960; DOI=10.1371/journal.pone.0011030; PMCID=PMC2882958
Choong L.Y., Lim S., Chong P.K., Wong C.Y., Shah N., Lim Y.P.
Proteome-wide profiling of the MCF10AT breast cancer progression model.
PLoS ONE 5:E11030-E11030(2010)